Elsevier

Pulmonary Pharmacology

Volume 9, Issue 1, February 1996, Pages 19-27
Pulmonary Pharmacology

Review
Airway and Systemic Effects of Inhaled Corticosteroids in Asthma: Dose Response Relationship

https://doi.org/10.1006/pulp.1996.0002Get rights and content

Abstract

No abstract

References (0)

Cited by (84)

  • Asthma

    2023, The Lancet
  • Advances in the design of new types of inhaled medicines

    2022, Progress in Medicinal Chemistry
    Citation Excerpt :

    In general, metabolic activity in the lungs is considered lower than in the gastrointestinal epithelium and the liver, at least for small molecules. For example, budesonide and fluticasone propionate were metabolised to 89% and 99% respectively for the swallowed part of the inhaled dose, while no metabolism was detected for the inhaled part, leading to the systemic bioactivity of both drugs being mainly determined by lung rather than gut bioavailability [77]. A potential advantage of inhaled drugs is the possibility to minimise systemic side effects by designing compounds with high systemic clearance combined with low oral bioavailability.

  • Oral inhalation for delivery of proteins and peptides to the lungs

    2021, European Journal of Pharmaceutics and Biopharmaceutics
    Citation Excerpt :

    This difference is particularly dramatic for small molecules. For example, fluticasone propionate was metabolized 99% when taken orally and 0% when inhaled [28]. However, degradation of proteins and peptides also occurs in the respiratory tract.

View all citing articles on Scopus
View full text